Recently, many results have been reported regarding the pluripotency of bone marrow cells (BMCs) with the aim of benefiting regenerative medicine for humans. Particularly, vessel formation by hematopoietic stem cells or vascular endothelial stem cells which were derived from bone marrow has received considerable interest, since the mechanism of vessel formation has been found to be involved in neoangiogenesis of serious diseases such as cancer. Most work on neoangiogenesis and regeneration has involved mammalian experimental systems, however the avian model is useful since the process of neoangiogenesis and regeneration of vessels can be observed with the whole embryo culture system. We have established a novel system using early chick embryos, where a portion of blood vessels are degenerated by UV irradiation, and vessel regeneration is then studied. Incubated embryos were partially covered with aluminum foil, from the embryonic body to the dorsal marginal vein, and irradiated with UV for 1 min. Donor BMCs were obtained from the femurs and tibias of chicks aged 10 days, fluorescently labeled with PKH26 and injected into the anterior vitelline vein of the recipients. In BMC-treated embryos the donor BMCs were observed around the UV-degenerated vessels, and regeneration of blood vessels occurred, in contrast to the untreated embryos. These results indicate that avian BMCs have the ability to participate in vessel regeneration, and the avian model used here may be a useful tool for studies of vessel neoangiogenesis and repair.

Keywords:
Blood vessels, Bone marrow biology, UV irradiation, Chick embryo
1.
Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, J.M. Isner (1997) Isolation of putative pro-genitor endothelial cells for angiogenesis. Science 275: 964–967.
2.
Carmeliet, P., E. Keshet (2001) A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 28: 1531–1538.
3.
Cumano, A., F. Dieterlen-Lièvre, I. Godin (1996) Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell 86: 907–916.
4.
Diaz-Trelles, R., J. Rodriguez-Leon, Y. Kawakami, J.C. Izpisua-Belmonte (2002) Expression of the chick vascular endothelial growth factor D gene during limb development. Mech Dev 116: 239–242.
5.
Dieterlen-Lièvre, F. (1975) On the origin of haemopoietic stem cells in the avian embryo: an experimental approach. J Embryol Exp Morphol 33: 607–619.
6.
Eichmann, A., B. Christ (1997) Expression of the avian VEGF receptor homologues Quek1 and Quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tissue Res 288: 207–223.
7.
Garcia-Porrero, J., I. Godin, F. Dieterlen-Lièvre (1995) Potential intraembryonic hemogenic sites at pre-liver stages in the mouse. Anat Embryol 192: 301–308.
8.
Gavard, J., J.S. Gutkind (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223–1234.
9.
Hamburger, V., H. Hamilton (1951) A series of normal stages in the development of the chick embryo. J Morphol 88: 49–82.
10.
Jaffredo, T., R. Gautier, A. Eichmann, F. Dieterlen-Lièvre (1998) Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 125: 4575–4583.
11.
Kawamoto, A., H.C. Gwon, H. Iwaguro, J.I. Yamaguchi, S. Uchida, H. Masuda, M. Silver, H. Ma, M. Kearney, J.M. Isner, T. Asahara (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634–637.
12.
Kobayashi, M., N. Nishikimi, K. Komori (2006) Current pathological and clinical aspects of Buerger’s disease in Japan. Ann Vasc Surg 20: 148–156.
13.
Kocher, A.A., M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, S. Homma, N.M. Edwards, S. Itescu (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430–436.
14.
Kuwana, T., T. Rogulska (1999) Migratory mechanisms of chick primordial germ cells toward gonadal anlage. Cell Mol Biol (Noisy-le-grand) 45: 725–736.
15.
Le Douarin, N.M., F. Dieterlen-Lièvre, P.D. Oliver (1984) Ontogeny of primary lymphoid organs and lymphoid stem cells. Am J Anat 170: 261–299.
16.
Medvinsky, A., E. Dzierzak (1996) Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86: 897–906.
17.
Moore, M.A.S., J.J.T. Owen (1965) Chromosome marker studies in the development of the hemopoietic system in the chick embryo. Nature 208: 956–989.
18.
Naito, M., K. Nirasawa, T. Oishi (1990) Development in culture of the chick embryo from fertilized ovum to hatching. J Exp Zool 254: 322–326.
19.
Pardanaud, L., A. Eichmann (2006) Identification, emergence and mobilization of circulating endothelial cells or progenitors in the embryo. Development 133: 2527–2537.
20.
Tavian, M., M.-F. Hallais, B. Peault (1999) Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo. Development 126: 793–803.
21.
Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
22.
Tufan, A.C., N.L. Satiroglu-Tufan (2003) The effect of ethanol exposure on extraembryonic vascular development in the chick area vasculosa. Cells Tissues Organs 175: 84–97.
23.
Turpen, J.B., C.M. Knudson (1982) Ontogeny of hematopoietic cells in Rana pipiens: precursor cell migration during embryogenesis. Dev Biol 89: 138–151.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.